MON -

NYSE American . Currency in USD
-
-
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Bayer CEO on Lower Earnings, Monsanto Purchase, Roundup
    Bloomberg Video2 months ago

    Bayer CEO on Lower Earnings, Monsanto Purchase, Roundup

    Sep.05 -- Werner Baumann, chief executive officer at Bayer, discusses the company's lower earnings forecast, the Monsanto purchase and the company's Roundup lawsuit. He speaks on "Bloomberg Markets: European Open."

  • Can Trump win on trade with little support at home?
    Yahoo Finance Video4 months ago

    Can Trump win on trade with little support at home?

    Following a tense G7, President Trump struggles to find support for his trade policies at home. Yahoo Finance's Seana Smith, Andy Serwer and Julia La Roche discuss.

  • Brazil court denies Monsanto bid to halt seed licensing to bankrupt firm
    Reuters4 days ago

    Brazil court denies Monsanto bid to halt seed licensing to bankrupt firm

    A Brazilian appeals court denied a request this month by Monsanto's local unit to suspend licensing of its popular Intacta soy seed technology to privately owned seed maker Sementes Talismã, according to a ruling seen by Reuters. Monsanto sought to suspend the licensing of the genetically modified seed technology after Talismã filed for bankruptcy protection in January, one of the seed maker's lawyers, Daniel Amaral of DASA Advogados in São Paulo, said. "Monsanto sought to end the licensing contract to try and negotiate better terms in Talismã's ongoing financial restructuring," Amaral said.

  • Jurors: Don't throw out $289M weed killer cancer verdict
    Associated Press6 days ago

    Jurors: Don't throw out $289M weed killer cancer verdict

    SAN FRANCISCO (AP) — Jurors who found that agribusiness giant Monsanto's Roundup weed killer contributed to a school groundskeeper's cancer are urging a San Francisco judge not to throw out the bulk of their $289 million award in his favor, a newspaper reported Monday.

  • Global executives cooling on deals amid trade uncertainty
    Associated Press14 days ago

    Global executives cooling on deals amid trade uncertainty

    LONDON (AP) — Executives around the world are cooling to the idea of mergers and acquisitions in the face of rising trade tensions, notably between the U.S. and China, a leading adviser on international corporate deals said Monday.

  • Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict
    Reuterslast month

    Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict

    The company said in motions filed in San Francisco's Superior Court of California that the jury's decision was insufficiently supported by the evidence presented at trial by school groundskeeper Dewayne Johnson. Johnson's case, filed in 2016, was fast-tracked for trial due to the severity of his non-Hodgkin's lymphoma, a cancer of the lymph system, that he alleged was caused by years of exposure to Roundup and Ranger Pro, another Monsanto herbicide that contains glyphosate. Monsanto asked Superior Court Judge Suzanne Bolanos, who oversaw the trial, to set aside the verdict or, in the alternative, reduce the award or grant a new trial.

  • Reuters2 months ago

    Bayer cuts forecasts on Monsanto delay as lawsuits pile up

    Bayer cut its earnings forecast on Wednesday due to delays to its $63 billion takeover of Monsanto, and said sales of its consumer care products fell, hitting its shares, already reeling from a legal battle over the weed killer Roundup. The weaker earnings forecast adds to a number of challenges facing the German drugmaker as it braces for years of legal wrangling over the alleged cancer risks of glyphosate-based weedkillers. Bayer said the number of plaintiffs seeking damages over Monsanto's Roundup and Ranger Pro herbicides had risen to 8,700 from 8,000 from last month, and said that it expected more to sue.

  • Reuters2 months ago

    EPA should revoke Monsanto weed killer approval, groups tell U.S. court

    The groups, which filed a lawsuit in February, want the court to force the EPA to vacate its approval of XtendiMax, arguing it not only harms nearby crops and plants but wildlife as well. It is not clear whether the court has the authority to revoke an EPA approval. The United States has faced a weed-killer crisis caused by the new formulations of dicamba-based herbicides, which farmers and weed experts say have harmed crops because they evaporate and drift away from where they are applied.

  • Reuters2 months ago

    Bayer says can begin integration of Monsanto

    Bayer can begin folding Monsanto into its organisation as the antitrust-related sale of assets has been completed, fulfilling final requirements by the U.S. Department of Justice, the German drugmaker said on Thursday. "The integration of Monsanto into the Bayer Group can begin following the completion on Thursday of the divestment by Bayer to BASF of certain Crop Science businesses with a total sales volume of around 2.2 billion euros," it said in a statement. Bayer already closed the deal, becoming the sole owner of Monsanto, on June 7 but had to hold off on the integration.

  • Reuters2 months ago

    Exclusive: U.S. seed sellers push for limits on Monsanto, BASF weed killer

    America's two biggest independent seed sellers, Beck's Hybrids and Stine Seed, told Reuters they are pushing U.S. environmental regulators to bar farmers from spraying dicamba weed killer during upcoming summers in a potential blow to Bayer AG's Monsanto Co. Limiting spraying of the chemical to the spring season, before crops are planted, would prevent farmers from using the herbicide on dicamba-resistant soybeans that Monsanto engineered. The seeds are sold by companies including Beck's and Stine.

  • Reuters2 months ago

    Analysis: Monsanto Roundup appeal has uphill climb on 'junk science' grounds - legal experts

    Bayer AG unit Monsanto faces long odds on an appeal blaming an "inflamed" jury and "junk science" for a verdict of $289 million in damages to a man who said the company's Roundup weed killer caused his cancer, according to some legal experts. Last week's verdict ended the first trial over whether glyphosate, the main ingredient in Roundup, causes cancer. Monsanto, which says decades of scientific studies have shown Roundup and glyphosate are safe, is facing about 5,000 similar lawsuits nationwide.

  • Monsanto Roundup appeal has uphill climb on 'junk science' grounds: legal experts
    Reuters2 months ago

    Monsanto Roundup appeal has uphill climb on 'junk science' grounds: legal experts

    Last week's verdict ended the first trial over whether glyphosate, the main ingredient in Roundup, causes cancer. Monsanto, which says decades of scientific studies have shown Roundup and glyphosate are safe, is facing about 5,000 similar lawsuits nationwide. Monsanto said on Monday it planned to challenge the verdict on the grounds that the judge should have barred scientific evidence presented by California school groundskeeper Dewayne Johnson's lawyers as insufficient.

  • Roundup cancer verdict sends Bayer shares sliding
    Reuters2 months ago

    Roundup cancer verdict sends Bayer shares sliding

    Bayer (BAYGn.DE) shares plunged as much as 14 percent on Monday, losing about $14 billion (£10.95 billion) in value, after newly acquired Monsanto was ordered to pay $289 million in damages in the first of possibly thousands of U.S. lawsuits over alleged links between a weedkiller and cancer. After the verdict in favour of a California school groundskeeper with terminal cancer, Monsanto faces more than 5,000 similar lawsuits across the United States over claims it did not warn of the cancer risks of glyphosate-based weedkillers, including its Roundup brand. Monsanto, bought by Bayer this year for $63 billion, said that it would appeal against the jury's verdict in California, which is the latest episode in a long-running debate over claims that exposure to Roundup can cause cancer.

  • Monsanto ordered to pay $289m to terminally ill groundsman who used Roundup weedkiller
    The Telegraph2 months ago

    Monsanto ordered to pay $289m to terminally ill groundsman who used Roundup weedkiller

    Monsanto ordered to pay $289m to terminally ill groundsman who used Roundup weedkiller

  • Jury backs man who claims Roundup weed killer caused cancer
    Associated Press2 months ago

    Jury backs man who claims Roundup weed killer caused cancer

    SAN FRANCISCO (AP) — A San Francisco jury on Friday ordered agribusiness giant Monsanto to pay $289 million to a former school groundskeeper dying of cancer, saying the company's popular Roundup weed killer contributed to his disease.

  • Reuters2 months ago

    Monsanto ordered to pay $289 million in world's first Roundup cancer trial

    The case of school groundskeeper Dewayne Johnson was the first lawsuit to go to trial alleging glyphosate causes cancer. Monsanto, a unit of Bayer AG (BAYGn.DE) following a $62.5 billion acquisition by the German conglomerate, faces more than 5,000 similar lawsuits across the United States. The jury at San Francisco's Superior Court of California deliberated for three days before finding that Monsanto had failed to warn Johnson and other consumers of the cancer risks posed by its weed killers.

  • InvestorPlace3 months ago

    Tesla Inc Whistleblower Continues to Rile Musk

    Martin Tripp, a former employee of Tesla Inc (NASDAQ:TSLA), is not backing down. The allegations include misleading statements from Tesla Inc about production levels of the Model 3 (by as much as 44%), damaged batteries (that included punctures) and the reuse of old parts. Well, Tesla Inc believes that Tripp hacked confidential information and provided it to third parties.

  • Monsanto’s Roundup Is on Trial. The Charge: Causing Cancer
    Fortune3 months ago

    Monsanto’s Roundup Is on Trial. The Charge: Causing Cancer

    The weed killer has been blamed for a former gardener's non-Hodgkin lymphoma.

  • Associated Press3 months ago

    Business Highlights

    As the trade war between the world's two largest economies nears the end of its first week, its most unsettling fact may be this: No one seems to foresee any clear path to peace. The United States insists that China abandon the brass-knuckles tactics it's used to try to supplant America's technological dominance. WASHINGTON (AP) -- Business groups and labor unions have lined up on opposing sides of the pitched battle shaping up over President Donald Trump's Supreme Court nominee, Brett Kavanaugh, whose approach to the law is widely seen as business-friendly.

  • Lawsuits alleging Roundup caused cancer can move forward
    Associated Press3 months ago

    Lawsuits alleging Roundup caused cancer can move forward

    SAN FRANCISCO (AP) — Hundreds of lawsuits alleging Roundup weed killer caused cancer cleared a big hurdle Tuesday when a U.S. judge ruled that cancer victims and their families could present expert testimony linking the herbicide to non-Hodgkin's lymphoma.

  • Reuters3 months ago

    U.S. judge allows lawsuits over Monsanto's Roundup to proceed to trial

    The decision by U.S. District Judge Vince Chhabria in San Francisco, California, followed years of litigation and weeks of hearings about the controversial science surrounding the safety of the chemical glyphosate, the key ingredient in Monsanto's top-selling weed-killer. Monsanto is a unit of Bayer AG (BAYGn.DE), following the $62.5 billion takeover of the U.S. seed major which wrapped up in June.

  • Monsanto may appeal Brazil royalties ruling
    Reuters3 months ago

    Monsanto may appeal Brazil royalties ruling

    Monsanto Co is considering appealing a Brazilian court ruling obliging it to deposit in an escrow account the royalties related to its Intacta RR2 Pro soy seed biotechnology, the company said in a statement on Tuesday. "Monsanto is weighing options for appealing (the ruling) and will take all measures to protect its legal rights," the statement said. Last week, a Brazilian judge ordered units of Monsanto Co to deposit the royalties related to that genetically modified seed in an escrow account pending the outcome of litigation over a patent dispute between Brazilian soy growers and the U.S. seeds company, now a unit of Bayer AG.

  • First trial over Roundup weed killer cancer claim under way
    Associated Press3 months ago

    First trial over Roundup weed killer cancer claim under way

    SAN FRANCISCO (AP) — Lawyers for a school groundskeeper dying of cancer asked a San Francisco jury on Monday to find that agribusiness giant Monsanto's widely used weed killer Roundup likely caused his disease.

  • Reuters4 months ago

    Brazil judge orders Monsanto to deposit royalties related to GMO seed

    A Brazilian judge has ordered local units of Monsanto Co to put royalties related to a GMO soy seed technology in an escrow account, in a decision likely to hinder the U.S. seed company's ability to collect royalties from the business. The July 3 ruling relates to a patent dispute between Brazilian soy growers in the state of Mato Grosso and Monsanto, which was recently acquired by Germany's Bayer AG in a 63 billion-euro deal. The judge ordered local units of Monsanto to deposit in an escrow account royalties related to the Intacta RR2 Pro genetically modified soy seed technology pending the end of the patent litigation, according to the decision seen by Reuters.

  • Moody's4 months ago

    Monsanto Finance Canada Co. -- Moody's downgrades Monsanto's ratings to Baa1; outlook negative

    Moody's Investors Service, ("Moody's") downgraded Monsanto Company's (Monsanto's) and Monsanto Finance Canada Co.'s long-term debt ratings to Baa1 from A3 due to its acquisition by Bayer AG (Baa1 negative) on June 7, 2018. Moody's also withdrew Monsanto's Prime-2 commercial paper rating.